BioFire Defense LLC
BioFire Defense is dedicated to delivering a fully integrated suite of biological agent identification products, including BioFire® FilmArray® and RAZOR® Mk II Systems, to the biodefense and first responder community. Their mission is to make the world a safer and healthier place by providing rapid detection systems for emerging infectious diseases and biothreats, supporting global health, and enhancing community security.
Industries
Nr. of Employees
medium (51-250)
BioFire Defense LLC
3850 N. University Ave, Provo, UT 84604
Patents
Assembly comprising a sample collection vessel and a separation container having seal, plunger with seal-piercing point, retainer, and flexible sealing member
US-11918998-B2
View Details
Assembly comprising a sample collection vessel and a separation container having seal, plunger with seal-piercing point, retainer, and flexible sealing member
US-11918998-B2
View DetailsProducts
Automated multiplex bio-detection instrument (small-footprint, closed system)
A compact, automated instrument that runs single-use pouch consumables to perform integrated sample preparation, amplification (including RT for RNA), and multiplex detection in a closed system for clinical and surveillance applications.
Portable field PCR detection system (rugged battery-capable unit)
A rugged, lightweight, battery-powered PCR instrument intended for field and first-responder use with features to support operation in protective gear and austere conditions.
Multiplex freeze-dried assay pouches and reagent kits
Single-use assay pouches containing freeze-dried reagents for multiplex detection panels covering clinical, bio-threat and food/water targets, formulated for ambient stability.
Automated multiplex bio-detection instrument (small-footprint, closed system)
A compact, automated instrument that runs single-use pouch consumables to perform integrated sample preparation, amplification (including RT for RNA), and multiplex detection in a closed system for clinical and surveillance applications.
Portable field PCR detection system (rugged battery-capable unit)
A rugged, lightweight, battery-powered PCR instrument intended for field and first-responder use with features to support operation in protective gear and austere conditions.
Multiplex freeze-dried assay pouches and reagent kits
Single-use assay pouches containing freeze-dried reagents for multiplex detection panels covering clinical, bio-threat and food/water targets, formulated for ambient stability.
Services
Provision of software modules and support to convert instrument results to electronic formats for transfer to laboratory information systems and to enable instrument-LIS connectivity.
On-site and remote installation, customer training, field troubleshooting, system upgrades and product return management for deployed instruments and assays.
Contract and in-house manufacturing capacity for reagent kits and diagnostic consumables, including participation in programs to expand domestic production capacity.
Provision of software modules and support to convert instrument results to electronic formats for transfer to laboratory information systems and to enable instrument-LIS connectivity.
On-site and remote installation, customer training, field troubleshooting, system upgrades and product return management for deployed instruments and assays.
Contract and in-house manufacturing capacity for reagent kits and diagnostic consumables, including participation in programs to expand domestic production capacity.
Expertise Areas
- Bio-surveillance and biodefense diagnostics
- Clinical molecular diagnostics
- Multiplex PCR assay development
- Point-of-care and field-deployable molecular instrumentation
Key Technologies
- Nested multiplex PCR
- Real-time PCR
- Reverse transcription (RT-PCR)
- Freeze-dried (lyophilized) assay pouches
News & Updates
BioFire Defense announced a DPA Title III agreement with DOD & HHS to expand domestic production of molecular diagnostic testing.
bioMérieux received Emergency Use Authorization for the BioFire COVID-19 Test, enabling rapid detection of SARS-CoV-2.
The Global Fever Panel was launched, testing for multiple pathogens causing fever in under an hour.
BioFire Defense received the 2014 Global New Product Innovation Award for its Ebola Test.
Received for outstanding industrial security excellence.
BioFire Defense announced a DPA Title III agreement with DOD & HHS to expand domestic production of molecular diagnostic testing.
bioMérieux received Emergency Use Authorization for the BioFire COVID-19 Test, enabling rapid detection of SARS-CoV-2.
The Global Fever Panel was launched, testing for multiple pathogens causing fever in under an hour.
BioFire Defense received the 2014 Global New Product Innovation Award for its Ebola Test.
Received for outstanding industrial security excellence.